Loading clinical trials...
Loading clinical trials...
Personalized Medicine for Canadians With Hemophilia: a Pragmatic Evaluation of the Web-Accessible Population Pharmacokinetics Service- Hemophilia (WAPPS-Hemo) Tailored Dosing.
Conditions
Interventions
Implementation of WAPPS-Hemo personalized dosing regimen
Locations
7
Canada
University of Calgary
Calgary, Alberta, Canada
University of Alberta
Edmonton, Alberta, Canada
University of British Columbia
Vancouver, British Columbia, Canada
University of Manitoba
Winnipeg, Manitoba, Canada
McMaster University
Hamilton, Ontario, Canada
McMaster University
Hamilton, Ontario, Canada
Start Date
July 24, 2019
Primary Completion Date
September 30, 2022
Completion Date
September 30, 2023
Last Updated
March 21, 2023
NCT06379789
NCT07226206
NCT05987449
NCT06008938
NCT04645199
NCT07080905
Lead Sponsor
McMaster University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions